167 related articles for article (PubMed ID: 33872749)
1. Effects of triangle grass decoction on bone metabolism in rats with chronic kidney disease complicated with mineral and bone abnormalities.
Liu L; Wang L; Li L; Wang H; Yuan L; Kang L; Jiang Q; Chen G; Lv N; Cui X; Huang L; Wu H; Xu J; Li Y
J Ethnopharmacol; 2021 Jul; 275():114126. PubMed ID: 33872749
[TBL] [Abstract][Full Text] [Related]
2. The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.
Ma X; He L
Biomed Pharmacother; 2018 Oct; 106():54-60. PubMed ID: 29957466
[TBL] [Abstract][Full Text] [Related]
3. [Bushen Huoxue Recipe Inhibited Vascular Calcification in Chronic Renal Failure Rats by Regulating BMP-2/Runx2/Osterix Signal Pathway].
Liu SY; Zhang N; Meng XF; Liu SW; Zhu HW; Li LF; Zhang CL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Mar; 36(3):327-32. PubMed ID: 27236891
[TBL] [Abstract][Full Text] [Related]
4. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
[TBL] [Abstract][Full Text] [Related]
5. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
6. Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt Eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG/AMPK signaling pathway.
Shen J; Liu Y; Wang Q; Chen H; Hu Y; Guo X; Liu X; Li Y
J Ethnopharmacol; 2023 Oct; 314():116590. PubMed ID: 37207881
[TBL] [Abstract][Full Text] [Related]
7. Inositol 1,4,5-trisphosphate receptor type 2 is associated with the bone-vessel axis in chronic kidney disease-mineral bone disorder.
Xiao Q; Tang Y; Luo H; Chen S; Tang Q; Chen R; Xiong L; Xiao J; Hong D; Wang L; Li G; Li Y
Ren Fail; 2023 Dec; 45(1):2162419. PubMed ID: 36645057
[No Abstract] [Full Text] [Related]
8. Relative comparison of chronic kidney disease-mineral and bone disorder rat models.
Zhang X; Li T; Wang L; Li Y; Ruan T; Guo X; Wang Q; Meng X
Front Physiol; 2023; 14():1083725. PubMed ID: 36818435
[No Abstract] [Full Text] [Related]
9. R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
Moe SM; Seifert MF; Chen NX; Sinders RM; Chen X; Duan D; Henley C; Martin D; Gattone VH
Nephrol Dial Transplant; 2009 Aug; 24(8):2371-7. PubMed ID: 19258382
[TBL] [Abstract][Full Text] [Related]
10. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
Mathew S; Davies M; Lund R; Saab G; Hruska KA
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
[TBL] [Abstract][Full Text] [Related]
11. Lanthanum Hydroxide and Chronic Kidney Disease Mineral and Bone Disorder: A Rat Model.
Gu C; Zhang T; Gao Y; Li X; Yuan X; Wang Q; Liu H; Han R; Li G
Curr Vasc Pharmacol; 2024; 22(2):122-136. PubMed ID: 37961858
[TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder.
Jiang JQ; Lin S; Xu PC; Zheng ZF; Jia JY
Nephrology (Carlton); 2011 Aug; 16(6):588-94. PubMed ID: 21649792
[TBL] [Abstract][Full Text] [Related]
13. Impact of miR-302b on Calcium-phosphorus Metabolism and Vascular Calcification of Rats with Chronic Renal Failure by Regulating BMP-2/Runx2/Osterix Signaling Pathway.
Sun WL; Wang N; Xu Y
Arch Med Res; 2018 Apr; 49(3):164-171. PubMed ID: 30119977
[TBL] [Abstract][Full Text] [Related]
14. Newly Developed Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
Watanabe K; Fujii H; Goto S; Nakai K; Kono K; Watanabe S; Shinohara M; Nishi S
J Atheroscler Thromb; 2018 Feb; 25(2):170-177. PubMed ID: 28674323
[TBL] [Abstract][Full Text] [Related]
15. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY; Chen LR; Chen KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia.
Graciolli FG; Neves KR; dos Reis LM; Graciolli RG; Noronha IL; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2009 May; 24(5):1416-21. PubMed ID: 19075196
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
[TBL] [Abstract][Full Text] [Related]
19. Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.
Chen NX; Srinivasan S; O'Neill K; Nickolas TL; Wallace JM; Allen MR; Metzger CE; Creecy A; Avin KG; Moe SM
J Bone Miner Res; 2020 Mar; 35(3):608-617. PubMed ID: 31743501
[TBL] [Abstract][Full Text] [Related]
20. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
